EPO and endometriosis: In addition to the use of EPO, we also used darbopoetin alpha (DARBE), which is a synthetic form of EPO, and methoxy polyethylene glycol-epoetin beta (MIRCERA), a long-acting EPO receptor activator, in order to assess their possible effects on the pathogenesis of endometriosis.